Condition: Constipation · Bloating · Sponsor: The University of Texas Health Science Center, Houston
The purpose of this study is to characterize the intestinal flora in subjects with systemic sclerosis-related constipation and/or significant bloating and to determine safety and trends in improvements in the diversity of colonic microbiome and patient symptoms following the administration of either frozen or lyophilized PRIM-DJ2727 microbiota.
This description comes directly from the study's public registry record.
Zsuzsanna McMahan, MD, MHS · 713-500-7531 · Zsuzsanna.H.McMahan@uth.tmc.edu
Ashish P Balar, MBBS, MPH · 713-500-4409 · Ashish.P.Balar@uth.tmc.edu
Always discuss trial participation with your own doctor first.
| The University of Texas Health Science Center at Houston | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06827977